On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

A new drug, NXP800, shows promise in treating hormone therapy-resistant prostate cancer by targeting the Heat Shock Factor 1 (HSF1) pathway, which supports cancer cell growth.

Hormone therapy is used to slow the progression of advanced prostate cancer, but cancers often develop resistance and continue to grow Research reveals that patients with higher levels of heat shock ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Prostate cancer, often linked to age-related hormonal changes and weakened immune function, presents symptoms like frequent ...

Today, on World Cancer Day, we come together to raise awareness, promote early detection and encourage prevention.

An innovative drug trialled for tackling certain cancers holds potential benefits for advanced prostate cancer patients whose current treatments have failed, scientists say. The breakthrough has ...